SMC No
INH
Symbicort (budesonide/formoterol) Turbohaler ® 100/6, 200/6 and 400/12 are indicated for adults and adolescents 12 years and older for regular treatment of asthma where the combined use of inhaled corticosteroids
Symbicort, 100 micrograms/3 micrograms/actuation pressurised inhalation, suspension - Summary of Product Characteristics (SmPC) - (emc)
Package leaflet: Information for the user
It contains two different medicines: budesonide and
It contains two different medicines: budesonide and formoterol fumarate dihydrate
SPC advises if taking Symbicort as reliever for the preventative use for allergen-or exercise-induced bronchoconstriction, an alternative reliever should be considered in case of frequent need of bronchodilation without corresponding need
We have developed a number of resources for your patients who have been prescribed Symbicort Turbohaler
This will provide relief by the rapid acting bronchodilation and also reduce
*Additional information is available within the SPC or upon request to the company
Summary of Product Characteristics last updated on medicines
• If symptoms persist after a few minutes, 1 additional inhalation should be taken
These side effects may go away during treatment as your body adjusts to the medicine
Symbicort (budesonide
Submission platform that supports Pharma in fulfilling their regulatory Symbicort Turbohaler is indicated in adults, adolescents, and children aged 6 years and older
20231003 Package Leaflet IE MT Symbicort TBH 200-6 AZ AB
Symbicort Turbohaler 200/6 Inhalation powder Summary of Product Characteristics
SYMBICORT 160/4
Symbicort 400 / 12 Turbohaler (AstraZeneca UK Ltd) 60 dose
cold symptoms such as stuffy or runny nose, sneezing, sinus pain, sore throat
The product code (s) for this leaflet is: PL 17901/0200